Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Journal of the American Heart Association|October 13, 2023
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 InhibitorsSaket Girotra, Amanda Stebbins, Lisa Wruck, et al.Atherosclerosis|September 7, 2016
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)Girum Mekonnen, Salim S Hayek, Puja K Mehta, et al.Journal of the American Heart Association|June 14, 2024
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary InterventionKayla R Tunehag, Cameron D Thomas, Francesco Franchi, et al.Circulation. Cardiovascular Interventions|July 28, 2023
EXACT Trial: Results of the Phase 1 Dose-Escalation StudyThomas J Povsic, Timothy D Henry, Jay H Traverse, et al.Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.Clinical Pharmacology and Therapeutics|April 16, 2022
Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-Site, Real-World InvestigationCameron D Thomas, Francesco Franchi, Ellen C Keeley, et al.Journal of the American College of Cardiology|April 10, 2024
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE ScoreCameron D Thomas, Francesco Franchi, Joseph S Rossi, et al.American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.JAMA|March 27, 2012
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trialEmerson C Perin, James T Willerson, Carl J Pepine, et al.JAMA|November 7, 2012
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trialJay H Traverse, Timothy D Henry, Carl J Pepine, et al.Pageof 10